Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Cancer Care Center of O'Fallon · O'Fallon, Illinois
Answer a few short questions to share with the research team.